Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Description

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Conditions

Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms, Leptomeningeal Cancer

Study Overview

Study Details

Study overview

The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.

Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis

Condition
Leptomeningeal Metastasis
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients (18 years or more), female or male
  • * Histologically confirmed diagnosis of extra-CNS primary solid cancer
  • * Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria
  • * Performance status compatible with enrolment into clinical trials
  • * Ability to consent
  • * Signed informed consent form from patient
  • * Participation in a parallel clinical trial is allowed in this non-interventional study
  • * Inability to give informed consent
  • * Inability to adhere to recommended follow-up according to the treating physician

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Zurich,

Study Record Dates

2026-12